Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VNN1 | O95497 | 3/20 | 0.41 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.40 |
| ▸ | CD274 | Q9NZQ7 | 3/20 | 0.39 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.39 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.39 |
| ▸ | MEP1B | Q16820 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL513250 | 0.80 | L3MBTL1 (0.56) | CYP2C9TBXAS1 | |
| SCHEMBL8437521 | 0.80 | L3MBTL1 (0.56) | CYP2C9TBXAS1 | |
| SCHEMBL513249 | 0.80 | L3MBTL1 (0.56) | CYP2C9TBXAS1 | |
| Hydrochloric Acid SCHEMBL8439653 | 0.79 | TBXAS1 (0.55) | CYP2C9TBXAS1 | |
| Hydrochloric Acid SCHEMBL8439652 | 0.79 | TBXAS1 (0.55) | CYP2C9TBXAS1 | |
| SCHEMBL28106835 | 0.79 | ALDH1A1 (0.51) | NR4A2ITGB1ITGA5 | |
| SCHEMBL14843314 | 0.79 | ALDH1A1 (0.51) | NR4A2ITGB1ITGA5 | |
| Bromide SCHEMBL16208931 | 0.77 | ALDH1A1 (0.50) | NR4A2ITGB1ITGA5 | |
| Hydrochloric Acid SCHEMBL16209092 | 0.77 | ALDH1A1 (0.50) | NR4A2ITGB1ITGA5 | |
| SCHEMBL6641420 | 0.77 | KCNH2 (0.40) | VNN1CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9290518-B2 | Water soluble metal-organic frameworks (MOFs) | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-03-22 | — | — | US | disclosed |
| US-20140330020-A1 | WATER SOLUBLE METAL-ORGANIC FRAMEWORKS (MOFS) | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2014-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140330020-A1 | WATER SOLUBLE METAL-ORGANIC FRAMEWORKS (MOFS) | SLC7A1, STOM, SLC6A15 | VNN1 1631/4885NR4A2 4620/4885CD274 610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.